Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Roberto Biagiotti is active.

Publication


Featured researches published by Roberto Biagiotti.


Neonatology | 2002

Umbilical cord care: The effect of eight different cord-care regimens on cord separation time and other outcomes

Marco Pezzati; Elena Cosenza Biagioli; Elena Martelli; Beatrice Gambi; Roberto Biagiotti; Firmino F. Rubaltelli

In this study we evaluate the effect of eight cord-care regimens on cord separation time and other secondary outcomes: omphalitis, sepsis, death, cord bleeding, compliance, satisfaction or dissatisfaction with regard to the type of treatment, umbilical cord colonization – in 1,535 healthy term infants. The eight cord-care regimens studied were: 70% alcohol, natural drying, salicylic sugar powder, triple dye, micronized green clay powder, colloid silver-benzyl-peroxide powder, neomycin-bacitracin powder, 1% basic fuchsine. None of the newborns developed sepsis or died and we found only sporadic cases of omphalitis. With regard to cord separation time the best results were obtained with salicylic sugar powder (5.6 ± 2.3 days) and green clay powder (6.7 ± 2.2 days). Both forms of treatment proved to be more effective (p < 0.05) than all the others. We found that salicylic sugar powder allows for early cord detachment resulting in excellent parent treatment compliance and reduction of their concern, notwithstanding higher percentages of cord bleeding. The rate of positive umbilical swabs was low and was significantly higher only than the results obtained with neomycin-bacitracin powder treatment. This study demonstrates that, in hospital nurseries of developed countries, salicylic sugar powder can be effectively and safely used for umbilical cord care of healthy term infants.


British Journal of Obstetrics and Gynaecology | 1998

First trimester screening for Down's syndrome using maternal serum PAPP-A and free β-hCG in combination with fetal nuchal translucency thickness

Roberto Biagiotti; Laura Brizn; Enrico Periti; Albertino D'Agata; Ermanno Vanzi; Ettore Cariati

The aim of this study was to evaluate the potential effectiveness of maternal serum pregnancy‐associated plasma protein A (PAPP‐A) and free β‐hCG in combination with nuchal translucency thickness in first trimester screening for Downs syndrome. Maternal serum levels of PAPP‐A and free β‐hCG were assayed in stored sera from 32 Downs syndrome and 200 unaffected pregnancies. Fetal nuchal translucency was measured by ultrasound at the time of blood sampling. Screening of Downs syndrome using a combination of maternal age, PAPP‐A, free β‐hCG and nuchal translucency would achieve a detection rate of 75.8% for a false positive rate of 5%.


European Journal of Obstetrics & Gynecology and Reproductive Biology | 1995

I. Aging of the human endometrium: a basic morphological and immunohistochemical study

Ivo Noci; Patrizia Borri; Orlando Chieffi; Gianfranco Scarselli; Roberto Biagiotti; Daniela Moncini; Milena Paglierani; Taddei Gl

OBJECTIVE To evaluate if human endometrium presents morphological variations suggestive of an age-related decline in endometrial receptivity. STUDY DESIGN Peri-implantation endometrium of younger (<30 years of age: n = 13) and older (>40 years of age: n = 17) normally menstruating women was studied. Endometrial specimens were routinely fixed in buffered formalin and embedded in paraffin. Sections (5 mu m) were stained with hematoxylin-eosin, periodic acid-Schiff (PAS) and Trichrome conforming to Masson according to conventional histologic examination. Several consecutive sections were used for the following immunohistochemical study: vascular localization (CD34), cellular proliferation index (PCNA), progesterone and estrogen receptors. RESULTS Using both the traditional morphological evaluation and monoclonal antibodies, no significant differences were found between the endometria of women <30 years of age and those of women >40. CONCLUSIONS Our results suggest that human endometrium does not age, at least while cyclic hormonal stimulation and menstruation are present.


Developmental Medicine & Child Neurology | 2002

Early postnatal Doppler assessment of cerebral blood flow velocity in healthy preterm and term infants

Marco Pezzati; Carlo Dani; Roberto Biadaioli; Luca Filippi; Roberto Biagiotti; Teresa Giani; Firmino F. Rubaltelli

The aim of the present study was to generate normal reference data for anterior and middle cerebral artery blood flow velocity and resistance index in preterm and term infants during the first 8 hours of life. The study population longitudinally included 120 healthy preterm and term infants (gestational age 24 to 41 weeks), all of appropriate weight for gestational age. The following parameters were studied: peak-systolic velocity, end-diastolic velocity, mean velocity, and resistance index. All parameters were measured in the anterior cerebral artery, in the left middle cerebral artery, and in the right middle cerebral artery with the use of Doppler colour ultrasonography. In addition, we studied the ratio of mean arterial blood pressure to mean velocity in the three cerebral arteries as a further estimate of cerebral relative vascular resistance. We found that cerebral blood flow velocities increased significantly with increasing gestational age and birthweight, both in the anterior cerebral artery and in the right and left middle cerebral arteries. Resistance index, both in the anterior cerebral artery and in the middle cerebral arteries, increased significantly only with increasing gestational age. Relative vascular resistance decreased significantly with increasing gestational age and birthweight in the three cerebral arteries. Significant differences were found (p<0.05) in these values between the anterior cerebral artery and the middle cerebral arteries. The narrow time frame (2 to 8 hours) that we used to evaluate cerebral blood flow velocity often represents a significant moment at which decisions are made that can be fundamental for the outcome of the newborn infant.


Gynecological Endocrinology | 2000

Effects of low day 3 luteinizing hormone levels on in vitro fertilization treatment outcome

Ivo Noci; Mario Maggi; Beatrice Fuzzi; Roberto Biagiotti; F. Ricci; Mauro Marchionni

In a previous study we demonstrated that women with day 3 luteinizing hormone (LH) values < 3 IU/l subjected to controlled ovarian hyperstimulation without pituitary desensitization responded with a lower number of follicles > 15 mm compared to women with a higher basal LH level. The aim of this study was to determine whether in patients with day 3 LH levels < 3 IU/l a further reduction of serum LH concentration by gonadotropin-releasing hormone (GnRH) analog impairs follicular response to follicle stimulating hormone (FSH) and treatment outcome in in vitro fertilization (IVF) cycles. For this purpose we retrospectively studied 249 consecutive women subjected to standard IVF treatment employing pituitary desensitization with buserelin and follicular stimulation with urinary highly purified FSH. The patients were divided into two groups according to their day 3 LH value. The first group (group A) showed day 3 LH levels < 3 IU/l and the second (group B) had day 3 LH levels > 3 IU/l. Group A and B patients did not show statistically significant differences in the ovarian response to FSH, nor in IVF treatment outcome, showing that in FSH treated GnRH analog suppressed cycles, the ovarian responsiveness and IVF outcome do not differ according to basal LH values. However, the high dosage of FSH we employed in group A and B patients could account, at least in part, for this result. Indeed, comparative evaluations with unsuppressed cycles (our previous study) strongly suggest that a reduced ovarian responsiveness to gonadotropins in patients with day 3 LH values < 3 IU/l should be considered in clinical practice.


British Journal of Obstetrics and Gynaecology | 1995

Maternal serum screening for Down's syndrome in the first trimester of pregnancy

Roberto Biagiotti; Ettore Cariati; Laura Brizzi; Alberino D'Agata

Biochemical screening for Down’s syndrome usually takes place in the second trimester of pregnancy. If effective maternal serum screening could be carried out in the first trimester, prenatal diagnosis using chorionic villous sampling (CVS) would allow for the identification of trisomy 21, and thus early pregnancy termination. Several studies have shown that alpha-fetoprotein and unconjugated oestriol (uE,) serum levels decrease in Down’s syndrome pregnancies during the first trimester (Brambati et al. 1986; Cuckle et al. 1988), while human chorionic gonadotrophin (hCG) levels are within the normal range (Cuckle et al. 1988). In contrast with hCG, free PhCG subunit levels have been found to be increased significantly in first trimester maternal serum from Down’s syndrome pregnancies (Spencer et al. 1992). In this report we evaluated first trimester maternal serum alpha-fetoprotein, uE, and hCG (intact and free P) to assess the efficacy of different combinations of these markers as a screening test for Down’s syndrome in the first trimester.


Acta Obstetricia et Gynecologica Scandinavica | 2001

Influence of maternal magnesium sulphate and ritodrine treatment on cerebral blood flow velocity of the preterm newborn

Marco Pezzati; Teresa Giani; Beatrice Gambi; Carlo Dani; Giovanna Bertini; Roberto Biagiotti; Firmino F. Rubaltelli

Background. To evaluate the effect of antenatal tocolytic administration of magnesium sulphate and ritodrine on the cerebral blood flow velocity and on the cerebral vascular resistance of preterm newborns in the first hours of life.


European Journal of Obstetrics & Gynecology and Reproductive Biology | 1995

Maternal serum CA 125 levels in first trimester abortion

Ivo Noci; Roberto Biagiotti; Enrico Periti; Daniele Baronci; Francesca Torricelli; Luisa Cefalà; Francesco Branconi; Patrizia Borri

OBJECTIVE To assess the source of maternal serum CA 125 during the first trimester of pregnancy. STUDY DESIGN CA 125 was measured in stored samples from nonviable pregnancies of 8-13 weeks gestation. The study group comprised 19 women with vaginal bleeding and 13 non-bleeders. Only patients in whom chromosome analysis of the products of conception demonstrated a normal caryotype were included. CA 125 levels were expressed in multiples of the median (MoM) for normal pregnancies of the same gestational age. RESULTS Median MoM values of CA 125 were significantly higher in women with vaginal bleeding (1.81 MoM) as compared both to non-bleeders (0.82 MoM; p < 0.01-Mann-Whitney U-test) and to the normal pregnancies (1.01 MoM; p < 0.05). No significant difference was found between non-bleeding women and controls. CONCLUSIONS The present study indicates that in non-viable pregnancies with euploid fetuses an increase in maternal serum CA 125 levels was found only in presence of decidual disruption associated to vaginal bleeding. These findings are compatible with a prevalent decidual source of this antigen.


European Journal of Obstetrics & Gynecology and Reproductive Biology | 1996

II. Aging of the human endometrium : peri-implantation phase endometrium does not show any age-dependent variation in lectin binding

Ivo Noci; Gheri G; Silvia Gheri Bryk; Eleonora Sgambati; Daniela Moncini; Milena Paglierani; Taddei Gl; Roberto Biagiotti; Patrizia Borri

OBJECTIVE To evaluate if the peri-implantation endometrium shows age variations in lectin patterns, which suggest possible age variations in embryo-maternal recognition. STUDY DESIGN Peri-implantation endometria of younger ( < 30 years of age: n = 13) and older ( > 40 years of age: n = 17) normally menstruating women was studied. Endometrial specimens were routinely fixed in buffered formaline and embedded in paraffin. Sections (5 microns) were studied using seven lectins: DBA (Dolicus biflorus, binding specificity alpha-D-GalNAc), PNA (Arachis hypogea, binding specificity D-Gal (beta 1 --> 3)-D-GalNAc), SBA (Glycine max binding specificity alpha/beta-D-GalNAc > D-Gal), WGA (Triticum vulgare binding specificity (alpha-D-GlcNAc)n and sialic acid), ConA (Canavalia ensiformis binding specificity alpha-D-Man > alpha-D-Glc), LTA (Lotus tetragonolobus binding specificity alpha-L-fucose) and UEA 1 (Ulex europaeus binding specificity alpha-L-fucose). RESULTS No significant differences were found in the glycoconjugates sugar residue content and distribution between the endometria of women < 30 years of age and those of women > 40. CONCLUSIONS Our results suggest that human endometrium does not age, at least while cyclic hormonal stimulation and menstruation are present.


Clinical Case Reports | 2015

Prenatal diagnosis of X-linked adrenoleukodystrophy associated with isolated pericardial effusion.

Giovanna Traficante; Roberto Biagiotti; Elena Andreucci; Mariarosaria Di Tommaso; Aldesia Provenzano; Ettore Cariati; Sabrina Giglio

This is the first reported case of fetal pericardial effusion in association with X‐linked adrenoleukodystrophy and hypocortisolism from a nonautoimmune cause. Our hypothesis is that in experienced hands and after accurate genetic counseling, isolated pericardial effusion can constitute an indication for a severe metabolic disease.

Collaboration


Dive into the Roberto Biagiotti's collaboration.

Top Co-Authors

Avatar

Ivo Noci

University of Florence

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ettore Cariati

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge